GPU-Accelerated Drug Discovery with Docking on the Summit Supercomputer: Porting, Optimization, and Application to COVID-19 Research

被引：30

作者：

LeGrand, Scott ^{[1
]}

Scheinberg, Aaron ^{[2
]}

Tillack, Andreas F. ^{[3
]}

Thavappiragasam, Mathialakan ^{[4
]}

Vermaas, Josh V. ^{[4
]}

Agarwal, Rupesh ^{[5
]}

Larkin, Jeff ^{[1
]}

Poole, Duncan ^{[1
]}

Santos-Martins, Diogo ^{[3
]}

Solis-Vasquez, Leonardo ^{[6
]}

Koch, Andreas ^{[6
]}

Forli, Stefano ^{[3
]}

Hernandez, Oscar ^{[4
]}

Smith, Jeremy C. ^{[5
,7
]}

Sedova, Ada ^{[4
]}

机构：

[1] NVIDIA Corp, Santa Clara, CA USA

[2] Jubilee Dev, Cambridge, MA USA

[3] Scripps Res, La Jolla, CA USA

[4] Oak Ridge Natl Lab, Oak Ridge, TN 37830 USA

[5] Univ Tennessee, Knoxville, TN USA

[6] Tech Univ Darmstadt, Darmstadt, Germany

[7] UT ORNL, Oak Ridge, TN USA

来源：

ACM-BCB 2020 - 11TH ACM CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS | 2020年

基金：

美国国家卫生研究院;

关键词：

Drug discovery; high-performance computing; GPU acceleration; protein-ligand docking; MOLECULAR DOCKING; AUTOMATED DOCKING; SYSTEM;

D O I：

10.1145/3388440.3412472

中图分类号：

TP39 [计算机的应用];

学科分类号：

081203 ; 0835 ;

摘要：

Protein-ligand docking is an in silico tool used to screen potential drug compounds for their ability to bind to a given protein receptor within a drug-discovery campaign. Experimental drug screening is expensive and time consuming, and it is desirable to carry out large scale docking calculations in a high-throughput manner to narrow the experimental search space. Few of the existing computational docking tools were designed with high performance computing in mind. Therefore, optimizations to maximize use of high-performance computational resources available at leadership-class computing facilities enables these facilities to be leveraged for drug discovery. Here we present the porting, optimization, and validation of the AutoDock-GPU program for the Summit supercomputer, and its application to initial compound screening efforts to target proteins of the SARS-CoV-2 virus responsible for the current COVID-19 pandemic.

引用

页数：10

共 37 条

[1] The Protein Data Bank
Berman, HM
Westbrook, J
Feng, Z
Gilliland, G
Bhat, TN
Weissig, H
Shindyalov, IN
Bourne, PE
[J]. NUCLEIC ACIDS RESEARCH, 2000, 28 (01) : 235 - 242
[2] Zeiler MD, 2012, Arxiv, DOI [arXiv:1212.5701, 10.48550/arXiv.1212.5701]
[3] Diogo Santos-Martins, 2019, ACCELERATING AUTODOC
[4] Reoptimization of MDL keys for use in drug discovery
Durant, JL
Leland, BA
Henry, DR
Nourse, JG
[J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2002, 42 (06): : 1273 - 1280
[5] VinaMPI: Facilitating multiple receptor high-throughput virtual docking on high-performance computers
Ellingson, Sally R.
Smith, Jeremy C.
Baudry, Jerome
[J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 2013, 34 (25) : 2212 - 2221
[6] GeauxDock: Accelerating Structure-Based Virtual Screening with Heterogeneous Computing
Fang, Ye
Ding, Yun
Feinstein, Wei P.
Koppelman, David M.
Moreno, Juana
Jarrell, Mark
Ramanujam, J.
Brylinski, Michal
[J]. PLOS ONE, 2016, 11 (07):
[7] Computational protein-ligand docking and virtual drug screening with the AutoDock suite
Forli, Stefano
Huey, Ruth
Pique, Michael E.
Sanner, Michel F.
Goodsell, David S.
Olson, Arthur J.
[J]. NATURE PROTOCOLS, 2016, 11 (05) : 905 - 919
[8] Enzyme assays for high-throughput screening
Goddard, JP
Reymond, JL
[J]. CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (04) : 314 - 322
[9] AUTOMATED DOCKING OF SUBSTRATES TO PROTEINS BY SIMULATED ANNEALING
GOODSELL, DS
OLSON, AJ
[J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1990, 8 (03): : 195 - 202
[10] An open-source drug discovery platform enables ultra-large virtual screens
Gorgulla, Christoph
Boeszoermenyi, Andras
Wang, Zi-Fu
Fischer, Patrick D.
Coote, Paul W.
Padmanabha Das, Krishna M.
Malets, Yehor S.
Radchenko, Dmytro S.
Moroz, Yurii S.
Scott, David A.
Fackeldey, Konstantin
Hoffmann, Moritz
Iavniuk, Iryna
Wagner, Gerhard
Arthanari, Haribabu
[J]. NATURE, 2020, 580 (7805) : 663 - +

← 1 2 3 4 →